BODENSTEDT MATTHIAS (Chief Financial Officer) purchased 1.8% of their position (10.87K shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market purchase worth $98.8K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/9/2025ACC: 0001213900-25-097594
Officer· Chief Financial Officer
Since Apr 2022
+10.87K
Net shares
Net buyer
$98.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10.87K acquired
Non-Derivative Transactions1
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
+10.87K
Price / share
$9.09
Trade value
$98.81K
% of position
1.8%
10/8/2025
616.67K→627.54K
Total
Net shares
+10.87K
Net value
$98.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Direct | 10/8/2025 | P · Purchase | +10.87K | $9.09 | $98.81K | 1.8% | 616.67K | 627.54K |
| Total | +10.87K | $98.81K | ||||||
Derivative Transactions0
No derivative transactions reported